Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sensory Contributions to Third Visual Pathway Dysfunction in Schizophrenia: Correlation and Causation

NCT07469384 is registered in ClinicalTrials.gov with Nathan Kline Institute for Psychiatric Research as lead sponsor.

NCT NCT07469384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07469384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sensory Contributions to Third Visual Pathway Dysfunction in Schizophrenia: Correlation and Causation
Lead sponsor
Nathan Kline Institute for Psychiatric Research
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2026
Completion date
July 31, 2030
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizo affective disorder, schizophrenia 1 (disorder)